Literature DB >> 15808766

Electrocardiography and Doppler echocardiography for risk stratification in patients with chronic heart failure: incremental prognostic value of QRS duration and a restrictive mitral filling pattern.

Christian Bruch1, Michael Gotzmann, Jörg Stypmann, Frauke Wenzelburger, Markus Rothenburger, Matthias Grude, Hans H Scheld, Lars Eckardt, Günter Breithardt, Thomas Wichter.   

Abstract

OBJECTIVES: This prospective study tested whether Doppler echocardiographic variables add incremental value to QRS duration in determining the prognosis of patients with chronic heart failure (CHF) and systolic dysfunction.
BACKGROUND: Diastolic dysfunction frequently is observed in patients with CHF, but its prognostic impact relative to that of QRS duration is unknown.
METHODS: A total of 193 patients with CHF and an ejection fraction <45% were enrolled prospectively. Echo measurements included left ventricular dimensions/volumes, ejection fraction, mitral early/late diastolic velocity ratio, deceleration time, and tissue Doppler mitral annular velocities. The mitral filling pattern was classified as either restrictive (RFP) or nonrestrictive. A cardiac event (cardiac death or urgent cardiac transplantation) was defined as combined study end point.
RESULTS: During a follow-up of 385 +/- 270 days, 24 patients suffered an event (cardiac death, n = 21; urgent transplantation, n = 3). The RFP, QRS duration, left ventricular systolic diameter, and mitral annular early diastolic velocity were independent predictors of an event. In patients with QRS duration >144 ms, the outcome was markedly poorer in the presence of RFPs as compared with their absence. Similarly, despite a QRS duration <or =144 ms, the outcome was worse in the presence of a RFP. A risk-stratification model based on the three strongest independent predictors separated groups into those with good prognosis and those with high, intermediate, and low event-free survival rates.
CONCLUSIONS: In subjects with CHF and systolic dysfunction, transmitral flow patterns add incremental value to QRS duration in determining the prognosis.

Entities:  

Mesh:

Year:  2005        PMID: 15808766     DOI: 10.1016/j.jacc.2004.12.064

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

Review 1.  The year 2005 in electrocardiology.

Authors:  Shlomo Stern
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-04       Impact factor: 1.468

2.  QRS and QTc interval prolongation in the prediction of long-term mortality of patients with acute destabilised heart failure.

Authors:  Tobias Breidthardt; Michael Christ; Miriam Matti; Delia Schrafl; Kirsten Laule; Markus Noveanu; Tujana Boldanova; Theresia Klima; Willibald Hochholzer; André P Perruchoud; Christian Mueller
Journal:  Heart       Date:  2007-03-29       Impact factor: 5.994

Review 3.  Heart failure, diastolic dysfunction and atrial fibrillation; mechanistic insight of a complex inter-relationship.

Authors:  J C Caldwell; M A Mamas
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

4.  Prognostic value of brain natriuretic peptide and enhanced ventilatory response to exercise in patients with chronic heart failure.

Authors:  Angela Beatrice Scardovi; Renata De Maria; Andrea Celestini; Claudio Coletta; Nadia Aspromonte; Silvia Perna; Marina Parolini; Roberto Ricci
Journal:  Intern Emerg Med       Date:  2008-06-17       Impact factor: 3.397

5.  Prognostic value of integrative analysis of electrical and mechanical dyssynchrony in patients with acute heart failure.

Authors:  Yanli Zhou; Zhuo He; Shengen Liao; Yanyun Liu; Li Zhang; Xu Zhu; Iokfai Cheang; Haifeng Zhang; Wenming Yao; Xinli Li; Weihua Zhou
Journal:  J Nucl Cardiol       Date:  2020-11-04       Impact factor: 5.952

6.  Short-term vs. long-term heart rate variability in ischemic cardiomyopathy risk stratification.

Authors:  Andreas Voss; Rico Schroeder; Montserrat Vallverdú; Steffen Schulz; Iwona Cygankiewicz; Rafael Vázquez; Antoni Bayés de Luna; Pere Caminal
Journal:  Front Physiol       Date:  2013-12-13       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.